Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
企業コードHSDT
会社名Helius Medical Technologies Inc
上場日Jun 27, 2014
最高経営責任者「CEO」Mr. Dane C. Andreeff
従業員数21
証券種類Ordinary Share
決算期末Jun 27
本社所在地642 Newtown Yardley Road
都市NEWTOWN
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号18940
電話番号12159446100
ウェブサイトhttps://heliusmedical.com/
企業コードHSDT
上場日Jun 27, 2014
最高経営責任者「CEO」Mr. Dane C. Andreeff
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし